4.6 Article

Potential of CeCl3@mSiO2 nanoparticles in alleviating diabetic cataract development and progression

期刊

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.nano.2016.12.021

关键词

Diabetic cataract; CeCl3@mSiO(2); Oxidative stress; Glutathione

资金

  1. National Natural Science Foundation of China [81100652, 51373117, 51303126, 31600800]
  2. International Science and Technology Cooperation Foundation of Shanghai [14430721100]
  3. Natural Science Foundation of Shanghai [16ZR1405200]

向作者/读者索取更多资源

Cataract is a major cause of visual impairment for diabetic patients. It is imperative to develop efficient therapeutic agents against diabetic cataract (DC) because diabetes confers higher risk for complications after cataract surgery. We have previously reported the role of CeCl3 loaded mesoporous silica (CeCl3@mSiO(2)) nanoparticles in reducing the oxidative stress of lens epithelial cells. However, the potential of CeCl3@mSiO(2) in preventing diabetic cataract development remains unclear. In this study, we applied CeCl3@ mSiO2 nanoparticles with a size of 87.6 +/- 8.9 nm to streptozotocin- induced diabetic cataract rat model by intraperitoneal injection. Our results showed that CeCl3@mSiO(2) efficiently ameliorated the progression of DC. Consistent with antioxidant effect of CeCl3@mSiO(2) in vitro, administration of CeCl3@mSiO(2) significantly abrogated hyperglycemia- mediated upregulation of advanced glycation end products, lipid peroxidation and protein carbonylation in animal lens. Taken together, our study provides a potential nanodrug to manage the development of DC. (C) 2017 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
Article Nanoscience & Nanotechnology

Therapeutic activity and biodistribution of a nano-sized polymer-dexamethasone conjugate intended for the targeted treatment of rheumatoid arthritis

Daniela Rubanova, Svitlana Skoroplyas, Alena Libanska, Eva Randarova, Josef Bryja, Michaela Chorvatova, Tomas Etrych, Lukas Kubala

Summary: This study explored the use of nanocarriers to deliver dexamethasone for treating rheumatoid arthritis. The results showed that this method increased the accumulation of dexamethasone in the arthritic area, had a dose-dependent healing effect, and reduced the accumulation of the RA mediator RANKL. This study provides a feasible strategy for improving rheumatoid arthritis therapy.

NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2024)

Article Nanoscience & Nanotechnology

Exploiting the ferroaddiction of pancreatic cancer cells using Fe-doped nanoparticles

Thanpisit Lomphithak, Apiwit Sae-Fung, Simone Sprio, Anna Tampieri, Siriporn Jitkaew, Bengt Fadeel

Summary: In this study, iron-doped hydroxyapatite (FeHA) was evaluated as a potential nanomedicine approach for treating PDAC. The results showed that FeHA, in combination with a sublethal dose of the GPX4 inhibitor RSL3, could trigger ferroptosis in KRAS mutant PANC-1 cells while sparing normal human cells. The induction of ferroptosis by FeHA plus RSL3 was found to be dependent on the metalloreductase STEAP3 in PDAC cells.

NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2024)

Review Nanoscience & Nanotechnology

Mechanism of escape from the antibacterial activity of metal-based nanoparticles in clinically relevant bacteria: A systematic review

Marco Felipe Salas-Orozco, Ana Cecilia Lorenzo-Leal, Idania de Alba Montero, Nuria Patino Marin, Miguel Angel Casillas Santana, Horacio Bach

Summary: The emergence of antibiotic-resistant bacteria in severe infections is a growing concern, particularly in hospital environments. Metal-based nanomaterials have shown potential as an alternative to combat these bacteria, but there is a risk of bacterial resistance and environmental accumulation.

NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2024)